Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 55154-0190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 55154-0190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10mg Bag Label (Df902d94 9d2b 4139 Aebb 3eb6b8b8cd54 00)

10mg Bag Label (Df902d94 9d2b 4139 Aebb 3eb6b8b8cd54 00)
This is a description of Cyclobenzaprine Hydrochloride tablets, USP 10 mg. The tablets are film-coated and each tablet contains 10 mg of Cyclobenzaprine hydrochloride. The usual adult dosage is one tablet (10 mg) three times a day. The packaging contains 10 tablets. Storage instructions include keeping the tablets at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59°F to 86°F). The package includes a warning that it is not child-resistant and is intended for institutional use only. The drug is from NDC #16571783, Rising Pharma Holdings, Inc., made in India. It is packaged and distributed by Majors Pharmaceuticals in Indianapolis, IN, USA, and distributed by Cardinal Health in Dublin, OH.*
FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical Structure (Cyclobenz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.